Skip to content

BELESSENTIAL: sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

BELESSENTIAL

BE 1001.518.565
NACE 47.730, Retail sale of pharmaceutical products
NACE division 47, Retail trade all sizesfiscal years 2023 to 202532,922 to 39,882 sector peers per ratio

Summary

fiscal year 2023

BELESSENTIAL does better than half of its sector on 3 of the 7 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Working-capital ratiobetter than 62%
  • Current ratiobetter than 52%
  • Solvencybetter than 50%
Points to watch
  • Return on equitybetter than 5%
  • Return on assetsbetter than 9%
  • Debt to equitybetter than 33%

Solvency and debt

How soundly the company is financed.
Solvency
34.0%2023

Solvency is around the median of 39,811 sector peers.

202320242025
Debt to equity
1.942023

Debt to equity is above 67% of 39,298 sector peers: less favourable than the median.

202320242025

Liquidity

Whether it can pay its short-term bills.
Current ratio
1.522023

The current ratio is above 52% of 39,678 sector peers: more favourable than the median.

202320242025
Quick ratio
0.592023

The quick ratio is below 63% of 39,706 sector peers: less favourable than the median.

202320242025
Working-capital ratio
34.0%2023

The working-capital ratio is above 62% of 39,728 sector peers: more favourable than the median.

202320242025

Profitability

What the company earns on its assets and its sales.
Return on equity
-64.2%2023

Return on equity is below 95% of 32,922 sector peers: in the least favourable quarter.

202320242025
Return on assets
-21.9%2023

Return on assets is below 91% of 39,882 sector peers: in the least favourable quarter.

202320242025

Not computable

Long-term debt ratio, Interest coverage, Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 28 September 2026 via checked.be.